Is the Origin and Emergence of SARS-CoV-2 Ingenuous?
The inability to identify the source of origin of SARS-CoV-2 even after more than twenty months of its emergence is intriguing and challenges the scientists and the public health personnel alike. Apprehension has been raised in certain quarters that some sort of human interference has taken place in the already dynamic gene pool of coronaviruses, which is a matter of concern. The need to have a scientific audit is paramount to unearth the real narrative about its origin as the precipitous assumption based on reports of human case incidences of infectious respiratory viral diseases having pandemic potential from a specific region is scientifically premature and it does not conclusively confirm the region to be the place of origin of the viral pathogen. Delineation of the source of origin of SARS-CoV-2 is vital for formulating strategies for the prevention of future outbreaks of viral zoonotic diseases if any, development of effective candidate vaccines, and designing target specific drugs. Further, this will put to rest the controversy about the origin and emergence of SARS-CoV-2 and create an ambience for cooperative functioning among the global stakeholders. It is pertinent to have comprehensive scrutiny of the laboratories conducting experimental research on coronaviruses particularly bat and other suspected mammalian betacoronaviruses to avert such calamitous situations in future. Mitigation of the disastrous effects of the COVID-19 pandemic is a global responsibility and necessitates joint efforts from all stakeholders across the globe.
How to cite this article:
Bhattacharya S, Tilak R, Bose C, Sinha S. Is the Origin and Emergence of SARS-CoV-2 Ingenuous? J Commun Dis. 2021;53(3):232-235.
Bhattacharya S, Sinha S, Tilak R, Mardihusodo SJ. The relationship between bats and human coronavirus: An
exploratory review. J Health Soc Sci. 2020;5(2):219-30. [Google Scholar]
Huang X, Zhang C, Pearce R, Omenn GS, Zhang Y. Identifying the zoonotic origin of SARS-CoV-2 by
modeling the binding affinity between the spike receptor-binding domain and host ACE2. J Proteome
Res. 2020 Dec;19(12):4844-56. [PubMed] [Google Scholar]
Lau SKP, Luk HKH, Wong ACP, Li KSM, Zhu L, He Z, Fung J, Chan TTY, Fung KSC, Woo PCY. Possible bat origin
of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020 Jul;26(7):1542-7. [PubMed]
Malik YA. Properties of coronavirus and SARS-CoV-2. Malays J Pathol. 2020 Apr;42(1):3-11. [PubMed]
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X,
Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497-506.
[PubMed] [Google Scholar]
Zhou H, Ji J, Chen X, Bi Y, Li J, Wang Q, Hu T, Song H, Zhao R, Chen Y, Cui M, Zhang Y, Hughes AC, Holmes
EC, Shi W. Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2
and related viruses. Cell. 2021 Aug;184(17):4380-91. e14. [PubMed] [Google Scholar]
Balaram P. The murky origins of the coronavirus SARSCoV-2, the causative agent of the COVID-19 pandemic.
Curr Sci. 2021;120(11):1663-6. [Google Scholar]
World Health Organization [Internet]. WHO Director-General’s opening remarks at the member state
information session on origins; 2021 [cited 2021 Jul 17]. Available from: https://www.who.int/directorgeneral/
Elrashdy F, Redwan EM, Uversky VN. Why COVID-19 transmission is more efficient and aggressive than
viral transmission in previous coronavirus epidemics? Biomolecules. 2020 Sep;10(9):1312. [PubMed] [Google
Tang X, Wu C, Li W, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, Cui J, Lu J. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020;7(6):1012–3. [Google Scholar]
Liu K, Tan S, Niu S, Wang J, Wu L, Sun H, Zhang Y, Pan X, Qu X, Du P, Meng Y, Jia Y, Chen Q, Deng C, Yan J, Wang HW, Wang Q, Qi J, Gao GF. Cross-species recognition of SARS-CoV-2 to bat ACE2. Proc Natl Acad Sci USA. 2021 Jan;118(1):e2020216118. [PubMed] [Google Scholar]
Segreto R, Deigin Y. The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2
chimeric structure and furin cleavage site might be the result of genetic manipulation. Bioessays. 2021
Mar;43(3):e2000240. [PubMed] [Google Scholar]
Hoffmann M, Kleine-Weber HA, Pöhlmann S. A multibasic cleavage site in the spike protein of SARSCoV-
is essential for infection of human lung cells.Mol Cell. 2020 May;78:779-84.e5. [PubMed] [Google
Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M,
Aljabali AAA, Lal A, Azad GK, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Questions
concerning the proximal origin of SARS-CoV-2. J Med Virol. 2021;93(3):1204-6. [PubMed] [Google Scholar]
Wu Y, Zhao S. Furin cleavage sites naturally occur in coronaviruses. Stem Cell Res. 2020 Dec;50:102115.
[PubMed] [Google Scholar]
Wang R, Chen J, Gao K, Hozumi Y, Yin C, Wei GW. Analysis of SARS-CoV-2 mutations in the United
States suggests presence of four substrains and novel variants. Commun Biol. 2021 Feb;4(1):228. [PubMed]
Chatterjee R, Bhattacharya S. Could novel corona virus (SARS-CoV-2) be the evolving face of a new generation
of genetically complex epidemiological challenge? Malays J Med Res. 2020;4(2):49-52. [Google Scholar]
World Health Organization [Internet]. Severe Acute Respiratory Syndrome (SARS); 2021 [cited 2021 Jul 4].
Goffard A, Demanche C, Arthur L, Pinçon C, Michaux J, Dubuisson J. Alphacoronaviruses detected in French
bats are phylogeographically linked to coronaviruses of European bats. Viruses. 2015 Dec;7:6279–90. [PubMed]
Smith CS, de Jong CE, Meers J, Henning J, Wang L, Field HE. Coronavirus infection and diversity in bats in the
Australasian region. Ecohealth. 2016 Mar;13(1):72-82. [PubMed] [Google Scholar]
Copyright (c) 2021 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.